FundComb
Confirmed Control Closed Transaction verified ConsumerConsumer Healthcare

GSK/Novartis Consumer Healthcare joint venture acquired by GlaxoSmithKline plc

GlaxoSmithKline plc acquired GSK/Novartis Consumer Healthcare joint venture, a consumer healthcare brand.

Transaction summary

Target
GSK/Novartis Consumer Healthcare joint venture
Seller
Novartis AG
Announced
-
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-10-18
Latest update
2026-10-18

Value and multiples

100% enterprise value

Undisclosed

Value not disclosed

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

-

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Enterprise value is unavailable.

Source summary

Haleon 20-F, filed 2026-03-13

Confirmed

Acquisition of GSK/Novartis Consumer Healthcare joint venture by GlaxoSmithKline plc.

Open source

Haleon 20-F, filed 2026-03-13

Confirmed

In June 2018, GSK acquired Novartis’ shareholding in the GSK/Novartis JV for $13bn, enabling GSK to take full operational and strategic control of the business.

Open source

Haleon 20-F, filed 2026-03-13

Confirmed

In June 2018, GSK acquired Novartis’ shareholding in the GSK/Novartis JV for $13bn

Open source

Continue your research

Related transaction comps

Explore more comps →
Consumer Healthcare

Hilma acquired by Biocodex

2022-11-17 · Confirmed

View transaction → Consumer Healthcare

Boehringer Ingelheim Consumer Healthcare business acquired by Sanofi

2016-06-27 · Estimated

View transaction → Consumer Healthcare

SSL International acquired by Reckitt Benckiser

2010-07-21 · Confirmed

View transaction → Consumer Healthcare

Tianjin TSKF Pharmaceutical Co., Ltd. acquired by Haleon plc

2025-06-27 · Confirmed

View transaction →